Chronic intraperitoneal insulin delivery, as compared with subcutaneous delivery, improves hepatic glucose metabolism in streptozotocin diabetic rats

被引:17
|
作者
Mason, TM
Gupta, N
Goh, T
El-Bahrani, B
Zannis, J
van de Werve, G
Giacca, A
机构
[1] Univ Toronto, Dept Physiol & Med, Toronto, ON M5S 1A8, Canada
[2] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2000年 / 49卷 / 11期
关键词
D O I
10.1053/meta.2000.17731
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have previously shown that chronic insulin treatment by the intraperitoneal route normalizes the elevated glucose production {GP} in streptozotocin (STZ) diabetic rats, while insulin delivered by the subcutaneous route only partially normalizes GP. To investigate the biochemical mechanism of the effect of chronic insulin delivery by either route on hepatic glucose metabolism, we measured the hepatic activity of glucose 6-phosphatase (G6Pase) and glucokinase (GK). Four groups of rats were used: (1) nondiabetic rats (N, n = 7), (2) untreated STZ diabetic rats (D, n = 8), (3) diabetic rats treated intraperitoneally (IP, n = 6), or (4) subcutaneously (SC, n = 8) (both 3 U of insulin/d). Glucose levels, higher in D, were normalized by insulin treatment regardless of route. Peripheral insulin levels were lowest in D and highest in SC as expected (N, 162 +/- 18 pmol/L; D, 66 +/- 12; IF, 360 +/- 96; SC, 798 +/- 198). STZ diabetes resulted in a 10-fold decrease in GK(P < .001), and a 2-fold increase in G6Pase activity (P < .01). Both intraperitoneal and subcutaneous treatments normalized G6Pase activity. In contrast, with subcutaneous but not intraperitoneal treatment, GK activity was still 35% less than normal (SC v N, P < .05). Glucose g-phosphate (G6P) levels did not differ among the groups. In summary: (I)the increase in GP in D reflected increased activity of G6Pase and reduced activity of GK, (2) the partial suppression of GP with subcutaneous insulin treatment reflected correction of increased G6Pase activity, but only partial correction of low GK activity, and (3) the normalization of GP with intraperitoneal insulin treatment reflected correction of both increased G6Pase activity and low GK activity. Our current studies indicate that chronic intraperitoneal insulin treatment is superior to subcutaneous treatment with regard to hepatic glucose metabolism. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:1411 / 1416
页数:6
相关论文
共 50 条
  • [31] Docetaxel Accumulates in Lymphatic Circulation Following Subcutaneous Delivery Compared to Intravenous Delivery in Rats
    Worley, Deanna R.
    Hansen, Ryan J.
    Wittenburg, Luke A.
    Chubb, Laura S.
    Gustafson, Daniel L.
    ANTICANCER RESEARCH, 2016, 36 (10) : 5071 - 5078
  • [32] Quantification of delays associated with intraperitoneal insulin delivery and IV glucose sensing aiming at closed loop insulin delivery
    Panteleon, AE
    Renard, E
    Han, JN
    Leong, P
    Rebrin, K
    Kolopp, M
    Steil, GM
    DIABETES, 2004, 53 : A105 - A105
  • [33] THE EFFECT OF INSULIN AND GLUCOSE DELIVERY ROUTE ON GLUCOSE-METABOLISM
    KUBOTA, M
    MORISHIMA, T
    KUBOTA, M
    KAWAMORI, R
    SHICHIRI, M
    KAMADA, T
    DIABETOLOGIA, 1988, 31 (07) : A511 - A511
  • [34] Insulin-like actions of tungstate in diabetic rats: Normalization of hepatic glucose metabolism
    1600, American Society for Biochemistry and Molecular Biology Inc., Bethesda, United States (269):
  • [35] Phloridzin reduces blood glucose levels and improves lipids metabolism in streptozotocin-induced diabetic rats
    Mahmood Najafian
    Mohammad Zareain Jahromi
    Mohammad Javad Nowroznejhad
    Parastoo Khajeaian
    Mohammad Mehdi Kargar
    Mehdi Sadeghi
    Amir Arasteh
    Molecular Biology Reports, 2012, 39 : 5299 - 5306
  • [36] Phloridzin reduces blood glucose levels and improves lipids metabolism in streptozotocin-induced diabetic rats
    Najafian, Mahmood
    Jahromi, Mohammad Zareain
    Nowroznejhad, Mohammad Javad
    Khajeaian, Parastoo
    Kargar, Mohammad Mehdi
    Sadeghi, Mehdi
    Arasteh, Amir
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (05) : 5299 - 5306
  • [37] INTRAPERITONEAL AND SUBCUTANEOUS GLUCAGON DELIVERY IN PIGS: EFFECTS ON CIRCULATING GLUCAGON AND GLUCOSE LEVELS
    Am, M. K.
    Dirnena-Fusini, I.
    Fougner, A. L.
    Carlsen, S. M.
    Christiansen, S. C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A48 - A48
  • [38] Zhenqing Recipe Improves Glucose Metabolism and Insulin Sensitivity by Repressing Hepatic FOXO1 in Type 2 Diabetic Rats
    Huang, Wenfan
    Yu, Jie
    Jia, Xuming
    Xiong, Liang
    Li, Ningxu
    Wen, Xiuying
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2012, 40 (04): : 721 - 733
  • [39] Microspheres for the oral delivery of insulin: preparation, evaluation and hypoglycaemic effect in streptozotocin-induced diabetic rats
    Zhang, Huan
    Wang, Weimei
    Li, Haoran
    Peng, Yi
    Zhang, Zhiqing
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (01) : 109 - 115
  • [40] Continuous automated insulin delivery based on subcutaneous glucose sensing and an external insulin
    Steil, GM
    Rebrin, K
    Hariri, F
    Chen, YL
    Darwin, C
    Saad, MF
    DIABETES, 2004, 53 : A3 - A3